Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Heymans

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
International Immunopharmacology|November 13, 2007
A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrineM J M Ezoulin, Z Liu, H Dutertre-Catella, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 14, 2006
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairmentM J M Ezoulin, C Z Dong, Z Liu, et al.
European Journal of Medicinal Chemistry|December 12, 2001
Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazinesC Binisti, L Assogba, E Touboul, et al.
The Bone & Joint Journal|March 16, 2023
Long-term functional outcome of secondary shoulder surgery in brachial plexus birth palsy patientsStijn G C J de Joode, Remco Meijer, Steven Samijo, et al.
Journal of Medicinal Chemistry|June 8, 2000
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replicationN Serradji, O Bensaid, M Martin, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
International Immunopharmacology|November 13, 2007
A new acetylcholinesterase inhibitor with anti-PAF activity modulates oxidative stress and pro-inflammatory mediators release in stimulated RAW 264.7 macrophage cells. Comparison with tacrineM J M Ezoulin, Z Liu, H Dutertre-Catella, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 14, 2006
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairmentM J M Ezoulin, C Z Dong, Z Liu, et al.
European Journal of Medicinal Chemistry|December 12, 2001
Structure-activity relationships in platelet-activating factor (PAF). 11-From PAF-antagonism to phospholipase A(2) inhibition: syntheses and structure-activity relationships in 1-arylsulfamido-2-alkylpiperazinesC Binisti, L Assogba, E Touboul, et al.
The Bone & Joint Journal|March 16, 2023
Long-term functional outcome of secondary shoulder surgery in brachial plexus birth palsy patientsStijn G C J de Joode, Remco Meijer, Steven Samijo, et al.
Journal of Medicinal Chemistry|June 8, 2000
Structure-activity relationships in platelet-activating factor (PAF). 10. From PAF antagonism to inhibition of HIV-1 replicationN Serradji, O Bensaid, M Martin, et al.
Pageof 4